ETORICOXIB-LOADED SOLID LIPID NANOPARTICLE DOSAGE FORM: FORMULATION, OPTIMIZATION, CHARACTERIZATION, STABILITY STUDYAND IN-VITRO IN-VIVO EVALUATION
Journal Title: International Journal of Pharmacy and Pharmaceutical Sciences - Year 2015, Vol 7, Issue 9
Abstract
Objective: The aim of present research work is to increase the bioavailability of poorly water soluble drug etoricoxib by developing solid lipid nanoparticle (SLN). Due to their unique size dependent properties, lipid nanoparticles offer the possibility to develop new therapeutics and enhance the bioavailability.Methods: An aqueous-based etoricoxib loaded solid lipid nanoparticles were prepared by hot and high speed homogenization technique, using different ratio of stearic acid and tripalmitin as lipid and different amount of pluronic F-68 as emulsifier. Optimization was done by surface response methodology (SRM) technique. The formulations are charecterised by drug content, drug entrapment efficiency, particle size and zea potential determination, SEM etc and evaluated by pharmacokinetic, pharmacodynamic and stability study.Results: Particle size distribution, entrapment efficiency and drug release were found 499.20 nm, 72% and 98.36% simultaneously, for selected optimized formulations. Zeta potential and span of optimized formulation found to be within the range of+34.2±0.9 and 0.29. in-vivo studies shows that pain reaction time (PRT) has increased from 6.2±0.42 to 8.45±0.19 second. Pharmacokinetic study shows an increasing remarkable result for Cmax which one is increased from 6274.290 μg ml−1 h to 8558.134 μg ml−1 h when compared with the standard formulation and for AUC it has been observed from 94202.963 mg. h. l-1 to 124310.201 mg. h. l-1Conclusion: Development of SLN formulations could be a better approach to increase the bioavailability of poorly water soluble drug like etoricoxib.Â
Authors and Affiliations
Subhra Prakash Bhattacharyya, Bhaskar Mazumder
Keywords
Related Articles
- EP ID EP578404
- DOI -
- Views 103
- Downloads 0
METHOD DEVELOPMENT FOR SIMULTANEOUS ANALYSIS OF MARKER SCOPOLETINE, ANDROGRAPHOLIDE, QUERCETIN, AND LUTEOLIN IN ANTIHYPERTENSION JAMU FORMULATION USING RP-HPLC
Objective: The aim of this research was to develop a method of simultaneous analysis marker compounds in antihypertension jamu formulation using reverse phase high performance liquid chromatography (RP-HPLC).Methods: Sta...
DEVELOPMENT OF HYDROPHILIC MATRIX TABLET OF CARBAMAZEPINE USING 33 FULL FACTORIAL EXPERIMENTAL DESIGNS
Objective: The study aims at developing the hydrophilic matrix tablet of carbamazepine (CBZ) using an optimization technique. The purpose of the study was to develop the hydrophilic matrix dosage form using the combinati...
COMPARATIVE STUDY OF THE ANTINOCICEPTIVE ACTION OF AMITRIPTYLINE WITH FLUOXETINE AND EVALUATION OF THEIR PROBABLE MECHANISM OF THIS ACTION IN ALBINO MICE
Objective: The aim of our study was to compare the anti-nociceptive action of amitriptyline with fluoxetine and evaluation of their probable mechanism of anti-nociceptive action by observing their individual interactions...
ENHANCEMENT OF LORNOXICAM SOLUBILITY BY INCLUSION COMPLEXATION WITH CYCLODEXTRIN: PREPARATION AND CHARACTERIZATION
Objective: Lornoxicam is a potent anti-inflammatory drug which has analgesic and antipyretic properties. It is water-insoluble powder. The inclusion complexes of lornoxicam (LOR) with β-cyclodextrin (βCD) and 2-hydroxy...
COMPARISON OF COMMERCIALLY AVAILABLE DRUGS FOR TYPE 2 DIABETES WITH NATURAL MOLECULE FROM TINOSPORA
Objective: Efficacy of natural molecule from Tinospora cordifolia versus commercially available drugs to control diabetes 2.Methods: Twelve different drug molecules were selected to study drug properties, bioactivity and...